TY - JOUR
T1 - Using algorithms to initiate needs-based interventions for people on antipsychotic medication
T2 - Implementation protocol
AU - Oakey-Neate, Lydia
AU - Schrader, Geoff
AU - Strobel, Jörg
AU - Bastiampillai, Tarun
AU - Van Kasteren, Yasmin
AU - Bidargaddi, Niranjan
N1 - Publisher Copyright:
© © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2020/2/12
Y1 - 2020/2/12
N2 - Introduction Non-adherence to antipsychotic medications for individuals with serious mental illness increases risk of relapse and hospitalisation. Real time monitoring of adherence would allow for early intervention. AI 2 is a both a personal nudging system and a clinical decision support tool that applies machine learning on Medicare prescription and benefits data to raise alerts when patients have discontinued antipsychotic medications without supervision, or when essential routine health checks have not been performed. Methods and analysis We outline two intervention models using AI 2. In the first use-case, the personal nudging system, patients receive text messages when an alert of a missed medication or routine health check is detected by AI 2. In the second use-case, as a clinical decision support tool, AI 2 generated alerts are presented as flags through a dashboard to the community mental health professionals. Implementation protocols for different scenarios of AI 2, along with a mixed-methods evaluation, are planned to identify pragmatic issues necessary to inform a larger randomised control trial, as well as improve the application. Ethics and dissemination This study protocol has been approved by The Southern Adelaide Clinical Human Research Ethics Committee. The dissemination of this trial will serve to inform further implementation of the AI 2 into daily personal and clinical practice.
AB - Introduction Non-adherence to antipsychotic medications for individuals with serious mental illness increases risk of relapse and hospitalisation. Real time monitoring of adherence would allow for early intervention. AI 2 is a both a personal nudging system and a clinical decision support tool that applies machine learning on Medicare prescription and benefits data to raise alerts when patients have discontinued antipsychotic medications without supervision, or when essential routine health checks have not been performed. Methods and analysis We outline two intervention models using AI 2. In the first use-case, the personal nudging system, patients receive text messages when an alert of a missed medication or routine health check is detected by AI 2. In the second use-case, as a clinical decision support tool, AI 2 generated alerts are presented as flags through a dashboard to the community mental health professionals. Implementation protocols for different scenarios of AI 2, along with a mixed-methods evaluation, are planned to identify pragmatic issues necessary to inform a larger randomised control trial, as well as improve the application. Ethics and dissemination This study protocol has been approved by The Southern Adelaide Clinical Human Research Ethics Committee. The dissemination of this trial will serve to inform further implementation of the AI 2 into daily personal and clinical practice.
KW - BMJ Health Informatics
KW - healthcare
KW - medical informatics
KW - patient care
KW - record systems
UR - https://www.scopus.com/pages/publications/85079338544
U2 - 10.1136/bmjhci-2019-100084
DO - 10.1136/bmjhci-2019-100084
M3 - Article
C2 - 32051177
AN - SCOPUS:85079338544
SN - 2632-1009
VL - 27
JO - BMJ Health and Care Informatics
JF - BMJ Health and Care Informatics
IS - 1
M1 - e100084
ER -